Gary H. Lyman, MD, MPH
Advertisement
Articles by Gary H. Lyman, MD, MPH
Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Advertisement
Latest Updated Articles
- Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Published: April 16th 2015 | Updated:
- Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Published: February 13th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine
2
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
3
Photobiomodulation, Bio-Machines, and the Future of Dermatology
4
Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026
5
